z-logo
open-access-imgOpen Access
Trans-catheter Bioprosthetic Heart Valve Implantation in Iran (Tehran Heart Centre Experiance)
Author(s) -
Ali Mohammad Haji Zeinali
Publication year - 2021
Publication title -
journal of shahid sadoughi university of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2228-5741
pISSN - 2228-5733
DOI - 10.18502/ssu.v29i9.7906
Subject(s) - medicine , catheter , heart valve , aortic valve , aortic valve replacement , cardiology , interventional cardiology , surgery , balloon catheter , aortic valve stenosis , stenosis
With the development of interventional cardiology in the world, in addition to coronary and aortic diseases, the treatment of heart valve diseases through catheters has recently begun. The treatment of aortic stenosis (which was only possible with open surgery and valve replacement) was first performed in the world in 2002 by Alain Cribier in France with catheter insertion of the valve and was called Trans catheter Aortic valve implantation TAVI. Trans catheter Aortic valve implantation (TAVI) was performed in Iran in 2009 in the Heart Centre of Tehran and now is routinely performed by both Balloon Expanding and self-expanding valves. In addition, we do valve in valve implantation for degenarative biopresthetic valve, in all Heart valve positions too. The short and medium term results of this treatment were reviewed in the form of research projects and published in several articles. In this review, we have explained the initiating of this new procedure in our country with the following results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom